1. Home
  2. Live Updates
  3. Ibd

Live Breaking News & Updates on Ibd

Stay informed with the latest breaking news from Ibd on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ibd and stay connected to the pulse of your community

Understanding Biologics for Patients With IBD

Experts discuss the warnings regarding IL-17 blockers and inflammatory bowel disease.

Biologics , Biologic-therapy , Oral-therapy , Shared-decision-making , Ibd , Il-17-blockers , Inflammatory-bowel-disease ,

Trust Point Inc. Invests $1.30 Million in Inspire Corporate Bond ETF (NYSEARCA:IBD)

Trust Point Inc. bought a new position in shares of Inspire Corporate Bond ETF (NYSEARCA:IBD – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 55,098 shares of the company’s stock, valued at approximately $1,300,000. Trust Point Inc. […]

Raymond-james-financial-services-advisors-inc , Atria-wealth-solutions-inc , Company-profile , Financial-group , Point-inc , Exchange-commission , Trust-point , Inspire-corporate-bond , Free-report , James-financial-services-advisors , Investment-advisers

Psoriasis Severity Tied to Increased Risk of Inflammatory Bowel Disease

A recent study identified a significant association between psoriasis and inflammatory bowel disease. This link also applied to IBD subtypes: Crohn disease and ulcerative colitis.

Israel , Ethical-committee , Meuhedet-health-maintenance-organization , Immunology , Psoriasis , Ibd ,

Marla Dubinsky, MD: Clinical Outcomes with Risankizumab Versus Ustekinumab in SEQUENCE

Dubinsky discusses findings from a post-hoc analysis of the head-to-head SEQUENCE trial of risankizumab versus ustekinumab in patients with Crohn disease refractory to anti-TNF therapy.

Stockholm , Sweden , Marla-dubinsky , Colitis-organisation-congress , Drug-administration , European-crohn , Mount-sinai-kravis-children , United-european-gastroenterology-week , Ibd , Inflammatory-bowel-disease , Crohn-x27s-disease , Ustekinumab

AGA Supports Fecal Microbiota-Based Therapies for C Diff in New Guideline

The guideline recommends fecal microbiota transplant in most cases of recurrent Clostridioides difficile infection but does not suggest fecal microbiota-based therapies for IBD or IBS.

United-states , American , Amanda-kabage , Anne-peery , University-of-north-carolina-school-medicine , American-gastroenterological-association , School-of-medicine-anne-peery , North-carolina-school , Cochrane-central-register , Controlled-trials , Cochrane-database , Systematic-reviews

Experts' Perspectives: AGA Recommends FMT for C Diff

Investigators from the guideline panel discuss the AGA’s recommendations regarding the use of fecal microbiota-based therapies for CDI, IBD, and IBS.

United-states , American , Osama-altayar , Colleen-kelly , Byron-vaughn , Harvard-medical-school , Washington-university-school-of-medicine , American-gastroenterological-association , University-of-minnesota , Washington-university , Fairview-health , Washington-university-school

Histological, Clinical Disease Activity Linked to Reduced Fertility in Women with IBD

Histological inflammation and clinical IBD activity were both associated with reduced fertility rates compared to histological remission and quiescent IBD.

Sweden , Gothenburg , Vastra-gotalands-lan , Swedish , University-of-gothenburg , International-classification-of-disease , Institute-of-clinical-sciences-at-sahlgrenska-academy , Swedish-national-patient-register , University-of-gothenburg-karl , Clinical-sciences , Sahlgrenska-academy

Marla Dubinsky, MD: Using Off-Label Treatments to Address the Unmet Need in Pediatric IBD

Marla Dubinsky, MD, discusses the use of off-label upadacitinib in pediatric IBD patients and the importance of this research due to delays in pediatric drug approvals.

Marla-dubinsky , Drug-administration , Mount-sinai-kravis-children , Mount-sinai , Ibd , Inflammatory-bowel-disease , Ulcerative-colitis , Crohn-x27s-disease , Upadacitinib , Anti-tnf , Adalimumab

'It's Completely Changed My Practice': Marla Dubinsky, MD, on Intestinal Ultrasound for Crohn's Disease

Marla Dubinsky, MD, discusses the use of segmental intestinal ultrasound to address screen failure associated with the SES-CD in clinical trials and for detecting transmural healing.

Marla-dubinsky , Simple-endoscopic-score , Crohn-disease , Crohn-disease-activity-index , Mount-sinai-kravis-children , Ibd , Inflammatory-bowel-disease , Ulcerative-colitis , Crohn-x27s-disease , Ultrasound , Simple-endoscopic-score-for-crohn-x27s-disease

Interchangeability, Adverse Event Considerations for Adalimumab Biosimilars in IBD

Patients who switched from originator adalimumab to a biosimilar experienced more treatment-emergent adverse events compared to those who stuck with the biosimilar or the reference drug.

Spain , Grenada , Eduardo-redondo-cerezo , Linkedin-eduardo-redondo-cerezo , University-of-grenada , Virgen-de-las-nieves-university-hospital , Ibd , Inflammatory-bowel-disease , Ulcerative-colitis , Crohn-x27s-disease , Persistence , Adalimumab